Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and Hypertriglyceridemia

thiazoles has been researched along with Hypertriglyceridemia in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (21.05)18.2507
2000's12 (63.16)29.6817
2010's3 (15.79)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bekkers, M; Lindahl, U; Lindén, D; Lindstedt, E; Nilsson, R; Oscarsson, J; Princen, H; van der Hoorn, J; Voskuilen, M1
Astudillo, AM; Balsinde, J; Barroso, E; Palomer, X; Rodríguez-Calvo, R; Serrano-Marco, L; Vázquez-Carrera, M1
Chung, WY; Lee, J1
Kazdova, L; Kren, V; Krenova, D; Seda, O1
Hoogwerf, BJ; Nambi, V; Sprecher, DL1
Fujioka, Y; Iwasaki, T; Masai, M; Morimoto, S; Ohyanagi, M; Okumura, T; Tsuboi, S; Tsujino, T1
Atkins, AR; Barish, GD; Collins, AR; Downes, M; Evans, RM; Hsueh, WA; Lee, CH; Liu, J; Lyon, CJ; Takata, Y; Tangirala, RK; Yin, F1
Bailey, P; Berger, J; Biswas, C; Cullinan, CA; Doebber, TW; Hayes, NS; Leibowitz, MD; Saperstein, R; Smith, RG1
Auwerx, J; Fruchart, JC; Schoonjans, K; Staels, B1
Matsui, K; Nagao, K; Shibata, T; Shinkai, H; Wakitani, K; Yonemori, F1
Hoekstra, JB; Kuck, EM; Wagenaar, LJ1
Basabe, JC; Chicco, A; Ferraris, N; Fortino, A; Karabatas, L; Lombardo, YB1
Johnson, JH; McCarthy, KJ; Routh, RE; Shaw, W; Walsh, K; Welbourne, TC1
Daubresse, JC1
Jacinto, SM; Ljung, B; Oakes, ND; Thalén, PG1
Harano, Y1
Chvojková, S; Divisová, J; Kazdová, L1
Demant, T1
Kane, JP1

Reviews

5 review(s) available for thiazoles and Hypertriglyceridemia

ArticleYear
A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia.
    Cleveland Clinic journal of medicine, 2002, Volume: 69, Issue:12

    Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Male; Metabolic Syndrome; Metformin; Motor Activity; Obesity; Simvastatin; Thiazoles; Thiazolidinediones; Weight Loss

2002
Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
    Journal of atherosclerosis and thrombosis, 1996, Volume: 3, Issue:2

    Topics: Animals; Clofibrate; Humans; Hypertriglyceridemia; Microbodies; Nuclear Proteins; Receptors, Cytoplasmic and Nuclear; Thiazoles; Transcription Factors; Triglycerides

1996
Troglitazone. Is it all over?
    The Netherlands journal of medicine, 1999, Volume: 55, Issue:1

    Topics: Animals; Blood Glucose; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Liver Function Tests; Male; Thiazoles; Thiazolidinediones; Troglitazone

1999
[The importance of syndrome X in daily practice].
    Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6

    Topics: Anthropometry; Cardiovascular Diseases; Diet, Reducing; Exercise; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Lipoproteins, HDL; Lipoproteins, LDL; Obesity; Rosiglitazone; Thiazoles; Thiazolidinediones

2000
[Lipodystrophia].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3

    Topics: Animals; Cardiomyopathy, Hypertrophic; Chromans; Diabetes Mellitus; Diagnosis, Differential; Fatty Liver; Humans; Hyperinsulinism; Hypertriglyceridemia; Insulin Resistance; Insulin-Like Growth Factor I; Lipid Metabolism; Lipodystrophy; Prognosis; Thiazoles; Thiazolidinediones; Troglitazone

2001

Other Studies

14 other study(ies) available for thiazoles and Hypertriglyceridemia

ArticleYear
Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.
    British journal of pharmacology, 2011, Volume: 162, Issue:7

    Topics: Aniline Compounds; Animals; Apolipoprotein E3; Atherosclerosis; Benzoates; Benzylamines; Cholesterol; Cytokines; Dose-Response Relationship, Drug; Fatty Liver; Female; Humans; Hypertriglyceridemia; Inflammation; Lipid Metabolism; Lipids; Liver; Liver X Receptors; Mice; Mice, Inbred C57BL; Mice, Transgenic; Orphan Nuclear Receptors; Thiazoles; Triglycerides

2011
The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
    Endocrinology, 2011, Volume: 152, Issue:5

    Topics: AMP-Activated Protein Kinases; Animals; Dietary Fats; Down-Regulation; Fatty Acids; Glucose Tolerance Test; Hypertriglyceridemia; Immunoblotting; Lipids; Liver; Mice; Nuclear Proteins; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphatidate Phosphatase; Phosphorylation; PPAR alpha; PPAR gamma; PPAR-beta; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thiazoles; Trans-Activators; Transcription Factors; Triglycerides

2011
The role played by the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) activator, GW501516, in control of fatty acid metabolism: a new potential therapeutic target for treating metabolic syndrome.
    Endocrinology, 2011, Volume: 152, Issue:5

    Topics: AMP-Activated Protein Kinases; Animals; Fatty Acids; Hypertriglyceridemia; Immunoblotting; Liver; Metabolic Syndrome; Mice; Nuclear Proteins; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphatidate Phosphatase; Phosphorylation; PPAR alpha; PPAR gamma; PPAR-beta; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thiazoles; Trans-Activators; Transcription Factors; Triglycerides

2011
Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain.
    Physiological genomics, 2003, Jan-15, Volume: 12, Issue:2

    Topics: Adipocytes; Adipose Tissue; Administration, Oral; Animals; Body Composition; CD36 Antigens; Diet; Dietary Sucrose; Glucose Intolerance; Glucose Tolerance Test; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Male; Rats; Rats, Inbred BN; Rats, Inbred SHR; Rosiglitazone; Thiazoles; Thiazolidinediones

2003
Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2003, Volume: 26, Issue:1

    Topics: Animals; Bezafibrate; Blood Glucose; Blood Platelets; Blood Pressure; Calcium; Chromans; Diet; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Fructose; Hydrogen-Ion Concentration; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Male; Propionates; Rats; Sodium-Hydrogen Exchangers; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Vasodilator Agents

2003
PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Mar-18, Volume: 105, Issue:11

    Topics: Adipokines; Angiotensin II; Animals; Atherosclerosis; Cell Movement; Enzyme Activation; Gene Expression Regulation; Hypercholesterolemia; Hypertriglyceridemia; Inflammation; Ligands; Macrophages; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; PPAR delta; Proto-Oncogene Proteins c-bcl-6; Receptors, LDL; Signal Transduction; Thiazoles; Transcription, Genetic

2008
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
    Endocrinology, 1996, Volume: 137, Issue:10

    Topics: Animals; Blood Glucose; COS Cells; Cricetinae; Diabetes Mellitus; Hyperglycemia; Hypertriglyceridemia; Insulin Resistance; Male; Mice; Molecular Conformation; Peptide Hydrolases; Receptors, Cytoplasmic and Nuclear; Thiazoles; Transcription Factors; Triglycerides

1996
Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    European journal of pharmacology, 1999, Jan-08, Volume: 364, Issue:2-3

    Topics: 3T3 Cells; Administration, Oral; Animals; Blood Glucose; Cell Differentiation; Chromans; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Isoxazoles; Male; Mice; Mice, Inbred Strains; Oxidation-Reduction; Pioglitazone; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides; Troglitazone

1999
Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:10

    Topics: Animals; Body Weight; Chromans; Dietary Sucrose; Fatty Acids, Nonesterified; Glucose; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Liver; Male; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone

2000
Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion.
    Kidney international, 2000, Volume: 58, Issue:6

    Topics: Animals; Basement Membrane; Body Weight; Chondroitin Sulfate Proteoglycans; Chromans; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibrosis; Glomerular Mesangium; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Islets of Langerhans; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Troglitazone

2000
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Diabetes, 2001, Volume: 50, Issue:5

    Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Fasting; Fatty Acids, Nonesterified; Glucose Clamp Technique; Humans; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Kinetics; Lipid Mobilization; Lipoproteins, VLDL; Liver; Male; Metabolic Clearance Rate; Muscle, Skeletal; Obesity; Oxidation-Reduction; Polyethylene Glycols; Postprandial Period; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Triglycerides

2001
A comparison of the effects of troglitazone and vitamin E on the fatty acid composition of serum phospholipids in an experimental model of insulin resistance.
    Physiological research, 2001, Volume: 50, Issue:3

    Topics: Animals; Antioxidants; Blood Glucose; Blood Pressure; Chromans; Disease Models, Animal; Fatty Acids; Female; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Rats; Rats, Mutant Strains; Rats, Wistar; Thiazoles; Thiazolidinediones; Troglitazone; Vitamin E

2001
[Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects].
    Fortschritte der Medizin. Originalien, 2001, Volume: 119, Issue:1

    Topics: Anticholesteremic Agents; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Chromans; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hyperlipoproteinemias; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Risk Factors; Simvastatin; Thiazoles; Thiazolidinediones; Troglitazone

2001
Does hypertriglyceridemia present an indication for pioglitazone therapy in diabetes?
    Diabetes technology & therapeutics, 2002, Volume: 4, Issue:2

    Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Pioglitazone; Thiazoles; Thiazolidinediones

2002